Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone.
Ho Won KangYoung Joon ByunSung Min MoonKyeong KimXuan-Mei PiaoChuang-Ming ZhengSung-Kwon MoonYoung Hyun ChoiWon Tae KimYong-June KimSang-Cheol LeeSeok-Joong YunWun Jae KimPublished in: Investigative and clinical urology (2022)
The expression ratio of urinary miR-H9 to miR-3659 could be a relevant non-invasive biomarker for PCa diagnosis, particularly for patients within the PSA gray zone.